Forty Percent Alarmist: What the Headlines Got Right (and Wrong) About AI Chatbot Harm
A new review finds 40% of news stories about chatbot harm use alarmist language, while clinical evidence is still catching up.
If you have been reading news stories about people in mental health crises after talking to AI chatbots, a new study can tell you something useful about what you have been reading. Researchers at McGill and the Université de Montréal pulled together every news article they could find that described a specific person whose psychiatric crisis was tied in time to using a generative AI chatbot. They found 71 articles covering 36 unique cases, published between September 16, 2025, and January 19, 2026. Then they coded the articles — not the cases — for tone, evidence, and framing. The result is the first systematic look at how the public is learning about this kind of harm, published in JMIR Mental Health.
The headline finding is in the headlines themselves. Forty percent of the articles led with alarmist language, another 11% with moral panic framing, 14% with concern or warning, and only 23% with neutral description. That is the register in which most readers are forming their picture of what these chatbots do to people.
The cases the articles describe are genuinely serious. Suicide death was the most frequently reported outcome — 35 of 61 cases where severity was clearly coded — followed by psychiatric hospitalization at 12. Children and teenagers carried more of the fatal outcomes than adults did. Among minors with a known severity rating, 90.5% of the cases were fatal, compared to 48.6% of adult cases. ChatGPT showed up in 71.8% of the articles, Character AI in 14.1% — and every single Character AI case in the dataset involved a minor.
Where the review gets uncomfortable is the evidence layer. The most common source of evidence in these stories was chat logs or screenshots, used in 34 of 61 articles. Police or medical records appeared in exactly one. And only 4 articles out of 71 mentioned any alternative explanation for what happened — things like a prior psychiatric diagnosis, sleep deprivation, substance use, or other stressors. The things a clinician would want to know before deciding a chatbot caused a death are mostly absent from the public record of that death.
This matters because the news cycle is shaping what regulators, parents, and clinicians think they know. Regulatory calls appeared in 85% of articles where that variable was coded, and lawsuits drove most of the coverage. Litigation supplies journalists with a defendant, a timeline, and discoverable transcripts — which is part of why a single settled case can still reshape an entire reporting environment. The cases that reach the public are disproportionately the ones that reach a courtroom.
None of this means the harms are imaginary. The review's authors are careful to say the opposite: rare but severe events in new technologies usually surface in journalism before they surface in epidemiology, and that is part of how safety science works. What the review does say, plainly, is that the public picture of AI-chatbot harm right now is shaped more by which stories travel than by what the clinical reality looks like across millions of users. The construct of "AI psychosis" is being assembled in headlines faster than in case series.
For anyone evaluating these systems, the practical takeaway is small and useful: building safety tests against the news cycle gives you a different product than building them against the underlying clinical risk. The first protects a company from the next lawsuit; the second protects a user from the next crisis.
This is the gap Metonym was built to address. Measuring clinical risk in conversational AI needs its own methodology — one anchored in what users actually experience, not in which tragedies happen to make the front page.
Metonym Clinical AI Intelligence — regulatory analysis at the intersection of clinical evaluation and AI safety. Produced under the Metonym Standard. Informational only — not legal advice, not clinical advice.